Formative-stage investor targeting behavioral inflection points across health, wealth, and upward mobility, using pattern-breaking evaluation to back non-obvious founders, especially women and diverse teams mainstream funds overlook. The firm continues to build its presence across the venture capital landscape.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Deliberate 60/40 tech/healthcare split dedicated to de novo company formation, with a transparent debate-driven partner scoring system (1–4) and proven multi-generation continuity. With a clear focus on healthcare innovation, the firm brings both capital and domain expertise.
Early-phase partner for founders building iconic, industry-transforming companies, demonstrated by two new funds totaling $347M. With a disciplined investment approach, the team drives value for both founders and investors.
Is dedicated to impactful businesses aiming to positively transform the world's food system.
Seed-stage investor in dual-use deep tech (six verticals) with an invite-only U.S. Service Academy alumni syndicate that co-invests, sources, vets deals, presents post-investment support, and runs a veteran-led track. The firm continues to build its presence across the venture capital landscape.
Invests at the concept stage, co-founding and building breakthrough life sciences and deep-science platforms directly with university researchers, acting as a company-builder partner to commercialize frontier biology. With a disciplined investment approach, the team drives value for both founders and investors.
Led by a solo GP, an early institutional investor that uses a learn-first networking approach—deep founder/category diligence—with bi-regional Columbus–Boulder presence centered on consumer, fashion, health/wellness, and brand+tech SaaS/IoT Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
